Humphries William D.
Insider CIK 1674278 · SSKN Director · PHAS Director · CLSD Director · ACRS Director · VRX President, Ortho-Dermatologics
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2026-06-05 | 2026-06-08 | 11,580 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2026-06-05 | 2026-06-08 | 11,580 | — | $0 | 45,105 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2026-06-04 | 2026-06-08 | 42,350 | — | $0 | 42,350 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2026-06-04 | 2026-06-08 | 10,987 | — | $0 | 10,987 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-06-06 | 2025-06-09 | 4,793 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-06-06 | 2025-06-09 | 4,793 | — | $0 | 33,525 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 11,580 | — | $0 | 11,580 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 42,350 | — | $0 | 42,350 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 15,750 | — | $0 | 15,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 4,793 | — | $0 | 4,793 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-06-01 | 2024-06-04 | 4,660 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-06-01 | 2024-06-04 | 4,660 | — | $0 | 28,732 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | M Exercise deriv | 2023-09-22 | 2023-09-22 | 22,727 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | M Exercise | 2023-09-22 | 2023-09-22 | 22,727 | $0.40 | $9.1K | 51,040 | SEC↗ |
| SSKN STRATA Skin Sciences, Inc. | A Award | 2023-07-05 | 2023-07-07 | 36,408 | $1.03 | $37.5K | 109,724 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2023-06-22 | 2023-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2023-06-02 | 2023-06-05 | 4,507 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2023-06-02 | 2023-06-05 | 4,507 | — | $0 | 24,072 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 15,750 | — | $0 | 15,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 4,660 | — | $0 | 4,660 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2023-05-19 | 2023-05-19 | 2,538 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise | 2023-05-19 | 2023-05-19 | 2,538 | — | $0 | 2,538 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2022-06-03 | 2022-06-06 | 3,356 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2022-06-03 | 2022-06-06 | 3,356 | — | $0 | 19,565 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 15,750 | — | $0 | 15,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 4,507 | — | $0 | 4,507 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2022-05-19 | 2022-05-20 | 17,500 | — | $0 | 17,500 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2022-05-19 | 2022-05-20 | 3,750 | — | $0 | 3,750 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2022-05-19 | 2022-06-10 | 2,538 | — | $0 | 2,538 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2022-05-19 | 2022-06-10 | 11,842 | — | $0 | 11,842 | SEC↗ |
| SSKN STRATA Skin Sciences, Inc. | P Buy | 2022-03-25 | 2022-03-28 | 16,950 | $1.73 | $29.3K | 484,440 | SEC↗ |
| SSKN STRATA Skin Sciences, Inc. | P Buy | 2022-03-24 | 2022-03-24 | 14,783 | $1.58 | $23.4K | 467,490 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | M Exercise deriv | 2022-01-10 | 2022-01-11 | 22,727 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | M Exercise | 2022-01-10 | 2022-01-11 | 22,727 | $0.15 | $3.4K | 28,313 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2021-09-14 | 2021-09-15 | 28,000 | — | $0 | 28,000 | SEC↗ |
| SSKN STRATA Skin Sciences, Inc. | A Award deriv | 2021-08-20 | 2021-08-23 | 411,124 | — | $0 | 452,707 | SEC↗ |
| SSKN STRATA Skin Sciences, Inc. | A Award | 2021-07-20 | 2021-07-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SSKN STRATA Skin Sciences, Inc. | A Award | 2021-07-20 | 2021-07-21 | 21,583 | — | $0 | 41,583 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2021-06-10 | 2021-06-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2021-06-03 | 2021-06-04 | 3,356 | — | $0 | 3,356 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2021-06-03 | 2021-06-04 | 12,250 | — | $0 | 12,250 | SEC↗ |
| BHC Bausch Health Companies In | M Exercise deriv | 2020-12-04 | 2020-12-08 | 114,055 | — | $0 | 0 | SEC↗ |
| BHC Bausch Health Companies In | M Exercise | 2020-12-04 | 2020-12-08 | 114,055 | $14.38 | $1.64M | 349,090 | SEC↗ |
| BHC Bausch Health Companies In | S Sale | 2020-12-04 | 2020-12-08 | 114,055 | $19.87 | $2.27M | 235,035 | SEC↗ |
| BHC Bausch Health Companies In | M Exercise deriv | 2020-11-27 | 2020-11-30 | 13,663 | — | $0 | 114,055 | SEC↗ |
| BHC Bausch Health Companies In | S Sale | 2020-11-27 | 2020-11-30 | 13,663 | $19.63 | $268.2K | 235,035 | SEC↗ |
| BHC Bausch Health Companies In | M Exercise | 2020-11-27 | 2020-11-30 | 13,663 | $14.38 | $196.5K | 248,698 | SEC↗ |
| BHC Bausch Health Companies In | M Exercise deriv | 2020-11-24 | 2020-11-30 | 21,658 | — | $0 | 127,718 | SEC↗ |
| BHC Bausch Health Companies In | M Exercise | 2020-11-24 | 2020-11-30 | 21,658 | $14.38 | $311.4K | 258,176 | SEC↗ |
| BHC Bausch Health Companies In | S Sale | 2020-11-24 | 2020-11-30 | 21,658 | $19.63 | $425.1K | 235,035 | SEC↗ |
| BHC Bausch Health Companies In | M Exercise deriv | 2020-11-23 | 2020-11-30 | 1,483 | — | $0 | 149,376 | SEC↗ |
| BHC Bausch Health Companies In | M Exercise | 2020-11-23 | 2020-11-30 | 1,483 | $14.38 | $21.3K | 236,518 | SEC↗ |
| BHC Bausch Health Companies In | S Sale | 2020-11-23 | 2020-11-30 | 1,483 | $19.63 | $29.1K | 235,035 | SEC↗ |
| BHC Bausch Health Companies In | S Sale | 2020-09-08 | 2020-09-10 | 5,667 | $16.17 | $91.6K | 235,035 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | P Buy | 2020-08-18 | 2020-08-18 | 5,586 | $1.78 | $9.9K | 5,586 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2020-08-17 | 2020-08-19 | 4,567 | $17.48 | $79.8K | 240,702 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2020-06-18 | 2020-06-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-06-06 | 2020-06-08 | 7,333 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-06-06 | 2020-06-08 | 7,333 | — | $0 | 16,209 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-06-04 | 2020-06-08 | 16,500 | — | $0 | 16,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-03-02 | 2020-03-04 | 8,876 | — | $0 | 8,876 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-03-02 | 2020-03-04 | 8,876 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-03-02 | 2020-03-04 | 8,876 | — | $0 | 8,876 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2020-02-28 | 2020-03-03 | 2,264 | $24.44 | $55.3K | 245,269 | SEC↗ |
| BHC Bausch Health Companies In | A Award deriv | 2020-02-26 | 2020-02-28 | 56,858 | — | $0 | 56,858 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2020-02-26 | 2020-02-28 | 13,506 | — | $0 | 247,533 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2020-02-20 | 2020-02-24 | 56,532 | $26.46 | $1.50M | 234,027 | SEC↗ |
| BHC Bausch Health Companies In | M Exercise deriv | 2020-02-19 | 2020-02-24 | 20,911 | — | $0 | 0 | SEC↗ |
| BHC Bausch Health Companies In | M Exercise | 2020-02-19 | 2020-02-24 | 20,911 | — | $0 | 184,776 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2020-02-19 | 2020-02-24 | 105,783 | — | $0 | 290,559 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2020-01-03 | 2020-01-07 | 14,559 | $29.92 | $435.6K | 163,865 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2019-08-16 | 2019-08-20 | 30,703 | — | $0 | 178,424 | SEC↗ |
| BHC Bausch Health Companies In | P Buy | 2019-08-16 | 2019-08-20 | 30,703 | $21.18 | $650.3K | 147,721 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2019-06-20 | 2019-06-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2019-06-06 | 2019-06-10 | 7,333 | — | $0 | 7,333 | SEC↗ |
| BHC Bausch Health Companies In | A Award deriv | 2019-02-27 | 2019-03-01 | 44,290 | — | $0 | 44,290 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2019-02-27 | 2019-03-01 | 15,221 | — | $0 | 117,018 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2019-01-03 | 2019-01-07 | 13,311 | $18.47 | $245.9K | 101,797 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2018-06-20 | 2018-06-21 | 11,250 | — | $0 | 11,250 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2018-06-07 | 2018-06-08 | 8,000 | — | $0 | 8,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2018-01-03 | 2018-01-05 | 14,730 | $20.78 | $306.1K | 115,108 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2017-06-30 | 2017-07-05 | 2,632 | — | $0 | 2,632 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2017-06-22 | 2017-06-23 | 8,618 | — | $0 | 8,618 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2017-06-15 | 2017-06-16 | 8,000 | — | $0 | 8,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award deriv | 2017-03-01 | 2017-03-03 | 150,859 | — | $0 | 150,859 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award deriv | 2017-01-02 | 2017-01-04 | 41,002 | — | $0 | 41,002 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2017-01-02 | 2017-01-04 | 129,838 | — | $0 | 129,838 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2016-09-01 | 2016-09-02 | 10,000 | — | $0 | 10,000 | SEC↗ |